US gov’t reveals drugs subject to Medicare price debate



The Biden administration announced on Tuesday in a statement the first 10 drugs that are eligible for Medicare price negotiation.

Among them are Eliquis and Xarelto, used for blood clot prevention; J…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento